Clinical Trial: Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Rotator Cuff Tendinopathy
Study Type: INTERVENTIONAL
Official Title: A Randomized, Parallel-group, 24 Week, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy and Safety of Secukinumab Compared to Placebo in Adult Patients With Active Ro
Brief Summary:
The purpose of the present study is to assess the efficacy of secukinumab 300 mg s.c.(subcutaneous) compared to placebo, each in combination with standard of care, in improving signs, symptoms and physical function in participants with moderate to severe rotator cuff tendinopathy (RCT), using a randomized, double-blind, placebo controlled, parallel group design to minimize bias.
Read more